CAR-TCR Summit is a world-renowned conference bringing together over 1000 industry leadersdeveloping CAR-TCR based therapies. Join pharma, biotech, regulatory bodies, academia, solution and service providers to discuss the next generation candidates beyond CD19, from solid tumor indications to autoimmune disorders.
MolMed Company Presentation e Hosting Partner
Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.
